ARL14 Human

ADP-Ribosylation Factor-Like 14 Human Recombinant
Shipped with Ice Packs
In Stock

Description

Molecular Structure and Basic Functions

ARL14 is a 196-amino-acid GTPase encoded by the ARL14 gene located on chromosome 13q14.2 . As a member of the ARL subfamily, it regulates membrane trafficking and cytoskeletal dynamics through GTP-dependent interactions with effector proteins. Key functional partners include:

Partner ProteinFunctionInteraction Score
PSD4Guanine nucleotide exchange factor for ARL14; controls MHC II-containing vesicle movement in dendritic cells .0.813
ARL14EPLinks ARL14 to MYO1E, facilitating vesicle transport along actin filaments .0.801
PLD1Phospholipase D1 activated by ARL14; implicated in membrane trafficking and signaling .0.540
LURAP1Modulates actomyosin retrograde flow via CDC42BPA/CDC42BPB and MYO18A interactions .0.490

ARL14 also interacts with ESCPE-1 complex components (e.g., SNX1) to regulate retrograde cargo trafficking .

Cellular Processes

  • Vesicle Transport: ARL14 recruits MYO1E to MHC II-containing vesicles via ARL14EP, enabling actin-dependent movement in dendritic cells .

  • Cytoskeletal Regulation: Activates CDC42BPA/CDC42BPB and MYO18A to phosphorylate myosin light chain (MYL9/MLC2), promoting actomyosin assembly and cell migration .

  • Inflammatory Signaling: Indirectly activates NF-κB pathways via LURAP1, enhancing proinflammatory cytokine production .

Cancer Pathogenesis

In NSCLC, ARL14 overexpression correlates with:

Expression Patterns

Tissue TypeARL14 ExpressionSurvival Correlation
NSCLC TumorsElevated compared to normal tissues (fold change: 2.3, P = 1.23E-06) .Negative correlation with OS (P = 4.12E-04) .
Lung AdenocarcinomaHigher in A549/PC9 cells vs. BEAS-2B/MRC-5 normal cells .Silencing reduces proliferation and migration .
Squamous Cell CarcinomaLinked to age (P = 0.003) and N stage (P = 0.009) .High expression shortens OS (HR = 4.329, P < 0.001) .

Mechanistic Insights

  • CIDEC/ERK/p38 Pathway: Silencing ARL14 inhibits CIDEC-mediated ERK/p38 signaling, reducing tumor cell invasion .

  • Immune Cell Infiltration: ssGSEA analysis reveals associations with neutrophil degranulation and interleukin signaling in squamous carcinomas .

Gene Ontology (GO) and KEGG Pathways

Cancer TypeGO TermsKEGG Pathways
Lung AdenocarcinomaEpidermal development, cell junction organization, focal adhesion .NOD-like receptor signaling, extracellular matrix organization .
Squamous Cell CarcinomaDNA replication, cell cycle regulation.Neutrophil degranulation, interleukin signaling .

GSEA-Detected Pathways

  • High ARL14 Expression: Enriched in keratinization (adenocarcinoma) and HDAC-mediated histone deacetylation .

Diagnostic and Therapeutic Potential

  • Prognostic Biomarker: Nomograms integrating ARL14 expression with clinical variables (age, N stage) predict 1-, 3-, and 5-year survival .

  • Therapeutic Target: Silencing ARL14 in lung adenocarcinoma cells suppresses growth and metastasis, with minimal effects on normal cells .

Unresolved Questions and Future Directions

  1. Tissue-Specific Expression: Recent BioID data suggest ARL14 is restricted to stomach/intestines, but its role in gastrointestinal cancers remains unexplored .

  2. PLD1 Activation: ARL14’s ability to activate PLD1 in cellulo warrants further study to elucidate lipid signaling mechanisms .

  3. Immune Modulation: Links to NF-κB and cytokine production necessitate investigation into ARL14’s role in tumor microenvironment regulation .

Product Specs

Introduction
The GTPase ARL14 (ADP-ribosylation factor-like 14) belongs to the ADP-ribosylation factor/ARF-like protein (ARF/ARL) family of Ras-related GTPases and exhibits developmental regulation. ARL14 functions as a GTPase that recruits MYO1E to MHC class II-containing vesicles. This recruitment is mediated by the effector protein C11orf46/ARF7EP and plays a crucial role in controlling the movement of these vesicles along the actin cytoskeleton within dendritic cells. The GTPase ARL14/ARF7 governs MHC-II transport by recruiting the motor myosin 1E through the effector protein ARF7EP.
Description
Recombinant ARL14 Human, produced in E. coli, is a single, non-glycosylated polypeptide chain consisting of 212 amino acids (residues 1-192) and possesses a molecular mass of 23.8 kDa. It's important to note that the molecular weight on SDS-PAGE will appear higher. This protein is engineered with a 20 amino acid His-tag fused at the N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
The product is a clear, colorless solution that has been sterilized by filtration.
Formulation
The ARL14 protein solution has a concentration of 0.25 mg/ml and is supplied in a buffer containing 20mM Tris-HCl (pH 8.0), 2mM DTT, 40% glycerol, 200mM NaCl, and 1mM EDTA.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the product frozen at -20°C. Adding a carrier protein like HSA or BSA (0.1%) is advised for long-term storage. To maintain product integrity, avoid repeated freeze-thaw cycles.
Purity
The purity of the ARL14 protein is greater than 90.0% as determined by SDS-PAGE analysis.
Synonyms

ADP-ribosylation factor-like protein 14, ADP-ribosylation factor 7, ARL14, ARF7, FLJ22595.

Source
Escherichia Coli.
Amino Acid Sequence

MGSSHHHHHH SSGLVPRGSH MGSLGSKNPQ TKQAQVLLLG LDSAGKSTLL YKLKLAKDIT TIPTIGFNVE MIELERNLSL TVWDVGGQEK MRTVWGCYCE NTDGLVYVVD STDKQRLEES QRQFEHILKN EHIKNVPVVL LANKQDMPGA LTAEDITRMF KVKKLCSDRN WYVQPCCALT GEGLAQGFRK LTGFVKSHMK SRGDTLAFFK QN.

Product Science Overview

Gene and Protein Structure

The ARL14 gene is located on chromosome 3 and encodes a protein that is 192 amino acids in length . The protein is expressed in various tissues and is involved in the regulation of vesicle movement along the actin cytoskeleton in dendritic cells . This movement is facilitated by the recruitment of MYO1E to MHC class II-containing vesicles via the effector protein ARL14EP .

Functional Role

ARL14 plays a crucial role in the immune system by controlling the movement of MHC class II-containing vesicles, which are essential for antigen presentation in dendritic cells . This function is vital for the immune response, as it helps in the activation of T-cells by presenting antigens on the cell surface .

Recombinant ARL14

Recombinant human ARL14 protein is produced using Escherichia coli expression systems and is purified to a high degree of purity (>90%) . This recombinant protein is used in various research applications, including mass spectrometry (MS) and sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) . The recombinant protein retains the functional properties of the native protein, making it a valuable tool for studying the biological functions of ARL14 .

Clinical Significance

Recent studies have suggested that ARL14 may serve as a prognostic biomarker in non-small cell lung cancer (NSCLC) . The expression levels of ARL14 have been correlated with the progression of NSCLC, indicating its potential role in cancer biology . Further research is needed to fully understand the implications of ARL14 in cancer and other diseases.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.